Lowie
SLowie100
#DEST – Destiny PharmaShares in issue – 59.8mMCAP – £58m at close 11/1/21TRADE ONLYXF73 is Destinys lead asset. Its potential use is prevention of post surgery staphylococcus aureus (MRSA –
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.